Assembly Biosciences is a clinical-stage biopharmaceutical company developing novel therapies for serious viral and liver diseases, including herpes viruses, hepatitis D, hepatitis B, and cholestatic liver diseases. The company has multiple ongoing clinical programs and is publicly traded.